| Literature DB >> 33584543 |
Marco Gallo1,2, Severo Campione3, Valentina Di Vito4, Nicoletta Fortunati1, Fabio Lo Calzo5, Erika Messina6, Rosaria Maddalena Ruggeri6, Antongiulio Faggiano4, Annamaria Anita Livia Colao5.
Abstract
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain. In the present short review of the medical literature on this topic, we have evaluated in details their epidemiology, risk factors, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. We have thus been able to identify a number of open issues regarding primary neuroendocrine neoplasms of the breast that need to be clarified. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.Entities:
Keywords: breast cancer; breast carcinoma; breast neuroendocrine neoplasms; neuroendocrine; review
Mesh:
Year: 2021 PMID: 33584543 PMCID: PMC7874233 DOI: 10.3389/fendo.2020.610230
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555